These stocks are gapping in today's session
By Mill Chart
Last update: Apr 3, 2024
Gapping stocks in Wednesday's session
Gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| UCAR | 9.0K% | U POWER LTD's (NASDAQ:UCAR) shares rose 9.0K% to $5.34 with a gap of 8.0K% during Wednesday's session. Shareholders saw the stock price going 57.12% lower in the past 3 months. |
| RENT | 2.0K% | RENT THE RUNWAY INC-A's (NASDAQ:RENT) shares rose 2.0K% to $6.34 with a gap of 2.0K% during Wednesday's session. The stock is trading 29.98% lower than 3 months ago. |
| KTRA | 79.18% | KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) stock price is advancing with 79.18% to a price of $0.18 with a gap of 70.92%. A press release (KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders) was released earlier today. |
| VNDA | 47.68% | VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) stock price is advancing with 47.68% to a price of $5.77 with a gap of 8.7%. The stock is trading 43.09% lower than a year ago. |
| ASXC | 30.27% | In today's session, ASENSUS SURGICAL INC's (NYSEARCA:ASXC) stock experienced a notable rise of 30.27%, reaching $0.28 with a remarkable gap of 22.49%. In the last month the stock lost 31.14%. |
| ONMD | 21.47% | Exciting news for ONEMEDNET CORP's (NASDAQ:ONMD) stock! It advanced 21.47% to $0.96 in today's session, accompanied by a substantial gap of 5.0%. Yesterday the company had a press release: OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth. |
| BREZW | 19.64% | Exciting news for BREEZE HOLDINGS ACQUIS -CW27's (NASDAQ:BREZW) stock! It advanced 19.64% to $1.34 in today's session, accompanied by a notable 3.08% gap. In the last month the share price increased with 138.0%. |
| COCHW | 19.36% | ENVOY MEDICAL INC-CW27's (NASDAQ:COCHW) shares soared 19.36% to $0.18 during Wednesday's session, accompanied by a significant gap of 5.32%. The stock is trading 654.0% higher than 3 months ago. |
| FEAM | 17.56% | 5E ADVANCED MATERIALS INC (NASDAQ:FEAM) rose 17.56% to $1.54 with a gap of 14.5% during Wednesday's session. A press release (5E Advanced Materials Commences Commercial Production At 5E Boron Americas Complex) was released yesterday. |
| HSDT | 16.43% | Exciting news for HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) stock! It advanced 16.43% to $6.59 in today's session, accompanied by a substantial gap of 5.81%. In the last 3 months the share price dropped with 26.97%. |
Our gap up stocks screener will show you the full list.
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| CASA | -77.48% | In today's session, CASA SYSTEMS INC's (NASDAQ:CASA) stock witnessed a 77.48% fall to $0.06 with a 83.37% gap. Earlier today the company had a press release: Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses. |
| VIEW | -61.91% | In today's session, VIEW INC's (NASDAQ:VIEW) stock price decreased by 61.91% to $0.42, exhibiting a 65.37% gap. Yesterday the company had a press release: View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company. |
| SINT | -41.08% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares fell 41.08% to $0.02 during Wednesday's session with a gap of 48.58%. In the last month the share price dropped with 69.84%. |
| MTNB | -34.37% | In today's session, MATINAS BIOPHARMA HOLDINGS I's (NYSEARCA:MTNB) stock witnessed a 34.37% fall to $0.23 with a 39.56% gap. Shareholders saw the stock price going 30.06% higher in the past month. |
| ANGH | -27.78% | ANGHAMI INC's (NASDAQ:ANGH) stock price is declining with 27.78% to a price of $1.3 with a gap of 44.49%. Shareholders saw the stock price going 93.03% higher in the past month. |
| TPET | -25.86% | TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares experienced a 25.86% decline to $0.11 during Wednesday's session, accompanied by a 54.3% gap. In the last month the stock gained 48.5%. |
| BCAN | -22.22% | BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 22.22% to $0.98 with a gap of 38.02%. A press release (Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023) was released yesterday. |
| FGEN | -21.76% | FIBROGEN INC's (NASDAQ:FGEN) shares declined by 21.76% to $1.69, showing a 27.47% gap in today's session. In the last 3 months the stock gained 188.0%. |
| TCON | -20.62% | In today's session, TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) stock witnessed a 20.62% fall to $0.33 with a 29.39% gap. A press release (TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned) was released earlier today. |
| SOL | -17.37% | In today's session, EMEREN GROUP LTD's (NYSE:SOL) stock witnessed a 17.37% fall to $1.95 with a 19.71% gap. In the last year the share price dropped with 42.58%. |
For the full top loser list go to our gap down stocks screener.
FIBROGEN INC
NASDAQ:FGEN (4/29/2024, 7:00:01 PM)
After market: 1.14 +0.05 (+4.59%)1.09
+0.05 (+4.81%)
FGEN News
SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after...
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of...
a month ago - Market News VideoNotable Wednesday Option Activity: FGEN, PLCE, MDBa month ago - Market News VideoCommit To Buy FibroGen At $1, Earn 44.2% Annualized Using OptionsFG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated,...
SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will...
a month ago - InvestorPlace3 Nightmare Nasdaq Stocks Not Worth Holding Another DaySelling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executive leader...
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
2 months ago - Seeking AlphaAstraZeneca returns right to roxadustat to FibroGen (NASDAQ:FGEN)AstraZeneca returns rights to FibroGen for roxadustat, a drug used for treating anemia related to chronic kidney disease. Read more here.
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246...
The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN FRANCISCO,...
